In the study by Zastrozhin et al. [17], a slow metabolism of the CYP2D6 was associated with changes in duloxetine concentration in the blood and higher levels of side effects during duloxetine therapy, which significantly affected the reduction in anxiety and depressive symptoms in our study. Here, CYP2D6 is linked to Anxiety.